|1.||Nakanuma, Yasuni: 25 articles (03/2015 - 07/2002)|
|2.||Sasaki, Motoko: 19 articles (03/2015 - 07/2002)|
|3.||Kubo, Shoji: 19 articles (01/2015 - 03/2002)|
|4.||Yamamoto, Masakazu: 16 articles (06/2015 - 06/2002)|
|5.||Uenishi, Takahiro: 15 articles (08/2014 - 03/2002)|
|6.||Sato, Yasunori: 13 articles (02/2015 - 12/2004)|
|7.||Pawlik, Timothy M: 13 articles (12/2014 - 03/2004)|
|8.||Maehara, Yoshihiko: 13 articles (08/2014 - 02/2004)|
|9.||Shimada, Mitsuo: 12 articles (09/2015 - 01/2002)|
|10.||Fan, Jia: 12 articles (05/2014 - 03/2006)|
06/01/2005 - "In conclusion, these data should be helpful for a better understanding of the tumorigenesis of intrahepatic cholangiocarcinoma and should contribute to the development of diagnostic and therapeutic strategies for this type of tumor. "
12/01/1997 - "In the evaluation of hilar or intrahepatic cholangiocarcinoma, delayed CT images are helpful for tumor characterization and may improve observer confidence for the presence of tumor. "
04/01/2014 - "This study indicates that circulating 2HG may be a surrogate biomarker of IDH1 or IDH2 mutation status in intrahepatic cholangiocarcinoma and that circulating 2HG levels may correlate directly with tumor burden. "
02/01/2014 - "Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization."
12/01/2013 - "In this study, we analyze a large set of intrahepatic cholangiocarcinoma tumors (n = 54) for mutations in these genes and compare the clinical outcomes of wild type versus KRAS and BRAF mutant cases. "
|2.||Neoplasm Metastasis (Metastasis)
03/01/2005 - "We report the case of a very rare 6-year disease-free survivor of intrahepatic cholangiocarcinoma with hilar lymph node metastasis and portal vein involvement. "
07/01/2001 - "Extended hepatic resection with a sufficient surgical margin yielded good results in intrahepatic cholangiocarcinoma patients without vascular invasion, intrahepatic metastasis, or lymph node metastasis. "
07/01/2014 - "Many studies suggest that lymph node metastasis in intrahepatic cholangiocarcinoma (ICC) is one of the strongest prognostic factors for patient survival; however, the status of the PAN was not examined separately from regional lymph node metastasis in these reports. "
06/01/2013 - "This study indicates that iNOS and COX-2 may play roles in carcinogenesis via biliary intraepithelial neoplasia, but play different roles in metastasis of intrahepatic cholangiocarcinoma. "
03/01/2013 - "This study sought to investigate the prognostic value of DKK1 in intrahepatic cholangiocarcinoma (ICC) and its role in promoting ICC metastasis. "
|3.||Hepatocellular Carcinoma (Hepatoma)
12/01/2008 - "It seems that a resection margin of 2 cm is associated with a decreased postoperative recurrence rate and improved survival outcomes especially for hepatocellular carcinoma <or= 2 cm. Due to the unsatisfying alternatives in the medical and interventional treatment of intrahepatic cholangiocarcinoma, hepatic resection, whenever technically possible, should be enforced. "
04/01/2015 - "The limited studies with 18F-fluorodeoxyglucose (18F-FDG)-PET reported results and interpretations that differed between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHCC). "
11/01/2013 - "The objective of this study was to determine the features of scirrhous hepatocellular carcinoma (sHCC) on gadoxetic acid-enhanced magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) with an emphasis on the differentiation from intrahepatic cholangiocarcinoma (ICC). "
01/01/2013 - "In this study, we compared patient characteristics and outcomes for primary CHC, intrahepatic cholangiocarcinoma (ICC), and hepatocellular carcinoma (HCC). "
04/01/2009 - "The purpose of this study was to compare MRI findings of diffuse hepatocellular carcinoma (D-HCC) and intrahepatic cholangiocarcinoma (IHC) to identify characteristics of each. "
12/01/2009 - "Of the 1,377 cases reviewed, 330 patients complied with the inclusion criteria and were thus eligible to participate in this study; 203 had intrahepatic cholangiocarcinoma and 127 had hilar cholangiocarcinoma. "
06/06/2007 - "The study included 1335 patients with intrahepatic cholangiocarcinoma and 1269 with extrahepatic cholangiocarcinoma. "
06/06/2007 - "Recent studies from several countries, including the United States, have indicated that the incidence rate of intrahepatic cholangiocarcinoma is increasing while that of extrahepatic cholangiocarcinoma is decreasing. "
06/21/2006 - "Recent studies in the United States that included this code (8162/3, Klatskin) with intrahepatic cholangiocarcinoma reported an increasing incidence of intrahepatic cholangiocarcinoma and a decreasing incidence of extrahepatic cholangiocarcinoma. "
10/01/2015 - "Cholangiocarcinoma is a heterogeneous malignant process, which is further classified into intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC). "
|5.||Colorectal Neoplasms (Colorectal Cancer)
02/01/2014 - "We aimed to evaluate FoxP3 promoter demethylation in human colorectal cancer (CRC) and rat intrahepatic cholangiocarcinoma (ICC). "
09/01/2008 - "CK7 and CK20 differentiated majority of intrahepatic cholangiocarcinoma from colorectal cancer liver metastasis, while CDX2 and MUC5AC helped to differentiate inconclusive cases. "
03/01/2011 - "This study aimed to evaluate the usefulness of immunohistochemical combinations for discrimination between intraepithelial ductal spread of colorectal carcinoma liver metastasis (CRLM) and that of intrahepatic cholangiocarcinoma (ICC). "
08/01/2015 - "Further data regarding different treatment paradigms for hepatocellular carcinoma, metastatic colorectal carcinoma, neuroendocrine tumours, and intrahepatic cholangiocarcinoma are also provided. "
11/01/2008 - "Fifteen patients (8 with colorectal carcinoma liver metastases, 7 with intrahepatic cholangiocarcinoma) were treated with 27 sessions of OEM-TACE. "
|2.||gadolinium ethoxybenzyl DTPA
|5.||Thorium Dioxide (Thorotrast)
|8.||Proteins (Proteins, Gene)
|10.||Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
|2.||Drug Therapy (Chemotherapy)
|4.||Lymph Node Excision (Lymph Node Dissection)